Phosphorylation-independent effects of CagA during interaction between Helicobacter pylori and T84 polarized monolayers

The Journal of Infectious Diseases
Sahar H El-EtrD Scott Merrell

Abstract

To extend our knowledge of host-cell targets of Helicobacter pylori, we characterized the interaction between H. pylori and human T84 epithelial cell polarized monolayers. Transcriptional analysis by use of human microarrays and a panel of isogenic H. pylori mutants revealed distinct responses to infection. Of the 670 genes whose expression changed, most (92%) required the cag pathogenicity island (PAI). Although altered expression of many genes was dependent on CagA (80% of the PAI-dependent genes), expression of >30% of these host genes occurred independent of the phosphorylation state of the CagA protein. Similarly, we found that injected CagA localized to the apical surface of cells and showed preferential accumulation at the apical junctions in a phosphorylation-independent manner. These data suggest the presence of distinct functional domains within the CagA protein that play essential roles in protein targeting and alteration of host-cell signaling pathways.

Citations

Jan 8, 2011·The Journal of Biological Chemistry·Christiane PelzRoger Vogelmann
Jun 21, 2011·Omics : a Journal of Integrative Biology·Fabio BagnoliRino Rappuoli
Oct 13, 2005·Current Opinion in Gastroenterology·Hong LuDavid Y Graham
Oct 28, 2008·Journal of Bacteriology·David A BaltrusKaren Guillemin
Nov 28, 2007·Annual Review of Pathology·John C Atherton
Aug 8, 2008·Cell Communication and Signaling : CCS·Sabine SchneiderSilja Wessler
Nov 23, 2006·International Journal of Hematology·Hidekazu SuzukiToshifumi Hibi
Aug 26, 2009·World Journal of Gastroenterology : WJG·Quan-Jiang DongShi-Ying Xuan
Mar 14, 2013·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Elham A KalafSaad N Sadwen
Nov 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Fabio BagnoliManuel R Amieva
Jul 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aime T FrancoRichard M Peek
Feb 21, 2013·Digestive Diseases and Sciences·Jia WuYongliang Zhu
Oct 17, 2015·Expert Review of Gastroenterology & Hepatology·Muhammad Miftahussurur, Yoshio Yamaoka
Sep 30, 2010·Cancer Investigation·Veronica Elizabeth Zavala-ZendejasErika Patricia Rendon-Huerta
Sep 24, 2005·Helicobacter·Céu FigueiredoYoshio Yamaoka
Jan 16, 2013·International Journal of Cancer. Journal International Du Cancer·Cosmeri RizzatoFederico Canzian
Mar 18, 2016·Scientific Reports·Luisa F Jiménez-Soto, Rainer Haas
Jan 13, 2006·Gastroenterology·Peter B ErnstSheila E Crowe
Nov 20, 2008·Journal of Medical Microbiology·Lam Tung NguyenMasatsugu Moriyama
May 17, 2017·Molecular Microbiology·Nicole TegtmeyerSteffen Backert
Oct 27, 2017·Gut and Liver·Thein MyintYoshio Yamaoka
Mar 30, 2007·Molecular Carcinogenesis·Gopal UdhayakumarHalagowder Devaraj
Oct 26, 2007·International Journal of Cancer. Journal International Du Cancer·Yo KurashimaMasanori Hatakeyama
Dec 20, 2005·The Journal of Pathology·Richard M Peek, Jean E Crabtree
Mar 25, 2006·International Journal of Cancer. Journal International Du Cancer·Masanori Hatakeyama
Sep 23, 2006·The Journal of Biological Chemistry·Maria J OliveiraCeu Figueiredo
Nov 3, 2015·World Journal of Gastroenterology : WJG·Tyler J CaronSusan J Hagen
Sep 27, 2018·World Journal of Gastrointestinal Oncology·Silvia Molina-CastroWarner Alpízar-Alpízar
Jun 17, 2011·Molecular and Cellular Biochemistry·Gopal UdhayakumarHalagowder Devaraj
Nov 1, 2017·World Journal of Gastroenterology : WJG·Michael T CairnsLokesh Joshi
Mar 12, 2019·Frontiers in Oncology·Khalid O AlfaroukSalvador Harguindey
Jun 8, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cristina Semino-MoraAndre Dubois

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.